Organoids are three-dimensional (3D) structures derived from adult or embryonic stem cells that maintain many structural and functional features of their respective organ. Recently, genome editing based on the bacterial defense mechanism CRISPR/Cas9 has emerged as an easily applicable and reliable laboratory tool. Combining organoids and CRISPR/Cas9 creates exciting new opportunities to study organ development and human disease in vitro. The potential applications of CRISPR in organoids are only beginning to be explored.
Benedetta Artegiani, Delilah Hendriks, Joep Beumer, Rutger N.U. Kok, Xuan Zheng, Indi P. Joore, Susana M. Chuva de Sousa Lopes, Jeroen S. van Zon, Sander J. Tans, Hans Clevers
Maarten H. Geurts, Eyleen de Poel, Cayetano Pleguezuelos‐Manzano, Rurika Oka, Léo Carrillo, Amanda Andersson-Rolf, Matteo Boretto, Jesse E Brunsveld, Ruben van Boxtel, Jeffrey M. Beekman, Hans Clevers
Victor Tirolle, Adrien Krug, Emma Bokobza, Mattijs Bulcaen, M. Ensinck, Maarten H. Geurts, Delilah Hendriks, F. Vermeulen, Frédéric Larbret, Alejandra Gutiérrez-Guerrero, Louise Medaer, Rik Gijsbers, Philippe Mangeot, Hans Clevers, Marianne S. Carlon, Frédéric Bost, Els Verhoeyen
Maarten H. Geurts, Eyleen de Poel, Cayetano Pleguezuelos‐Manzano, Léo Carrillo, Amanda Andersson-Rolf, Matteo Boretto, Jeffrey M. Beekman, Hans Clevers
Discussion(0)
No comments yet. Be the first to comment.